Facing ongoing competitive pressures and market growth demands, life science and biomedical original equipment manufacturers (OEMs) must constantly deliver new advancements in technology, processes, workflows, and production. But in addition to pursuing improvements that focus on expanding success, OEMs must also ensure against the in-use failures of their advanced equipment.
In the case of advanced instruments used in research, scientific, medical, and other critical applications, neglecting improvements and safeguards in one seemingly minor component – in-process linear motion systems – can generate consequences ranging from inconvenient to catastrophic.
This white paper highlights how next-generation linear motion systems can be specified, designed, installed, and maintained to both advance life science and biomedical capital equipment manufacturing – and ensure against failures of any consequence.
Latest from Today's Medical Developments
- Zimmer Biomet to acquire Paragon 28
- Industrie 4.0 award for Paul Horn GmbH
- CMMC requirements and your business
- Stryker exiting spinal implant business
- Perfecting the manufacture of microscopically thin films for tech, medical applications
- Find out what 2025 holds for design and manufacturing
- Montagu to merge Tyber Medical, Intech and Resolve Surgical Technologies
- Americhem’s EcoLube MD PFAS-free internally lubricated compounds